Cohort Study: SGLT2 and Risk of Serious Adverse Events

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study – The BMJ (free)

Commentaries: New diabetes drug may increase the risk of serious adverse events – Karolinska Institutet (free) AND SGLT2 Inhibitors Tied to Increased Risk for Amputation, Diabetic Ketoacidosis – NEJM Journal Watch (free) AND SGLT2 Inhibitor Amputation Risk Seen in Real-World Diabetes Study – Medscape (free registration required)